Effects of red blood cell transfusions given to non-septic critically ill patients: a propensity score matched study.

circulatory failure days alive and free erythrocyte transfusion. mortality renal failure respiratory failure blood transfusion

Journal

Anaesthesiology intensive therapy
ISSN: 1731-2531
Titre abrégé: Anaesthesiol Intensive Ther
Pays: Poland
ID NLM: 101472620

Informations de publication

Date de publication:
2021
Historique:
entrez: 1 2 2022
pubmed: 2 2 2022
medline: 9 3 2022
Statut: ppublish

Résumé

Previous studies have demonstrated that low-grade red blood cell transfusions (RBC) given to septic patients are harmful. The objectives of the present study were to compare mortality and morbidity in non-septic critically ill patients who were given low-grade RBC transfusions at haemoglobin level > 70 γ L-1 with patients without RBC-transfusions any of the first 5 days in intensive care. Adult patients admitted to a general intensive care unit between 2007 and 2018 at a university hospital were eligible for inclusion. Patients who received > 2 units RBC transfusion per day during the first 5 days after admisasion, with pre-transfusion haemoglobin level < 70 γ L-1 or with severe sepsis or septic shock, were excluded. In total, 9491 admissions were recorded during the study period. Propensity score matching resulted in 2 well matched groups with 674 unique patients in each. Median pre-transfusion haemoglobin was 98 γ L-1 (interquartile range 91-107 γ L-1). Mortality was higher in the RBC group with an absolute risk increase for death at 180 days of 5.9% (95% CI: 3.6-8.3; P < 0.001). Low-grade RBC-transfusion was also associated with renal, circulatory, and respiratory failure as well as a higher SOFA-max score. Sensitivity analyses suggested that disease trajectories during the exposure time did not significantly differ between the groups. Low-grade RBC-transfusions given to non-septic critically ill patients without significant anaemia were associated with increased mortality, increased kidney, circulatory, and respiratory failure, as well as higher SOFA-max score.

Identifiants

pubmed: 35100796
pii: 45862
doi: 10.5114/ait.2021.111739
pmc: PMC10172944
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

390-397

Références

J Crit Care. 2018 Oct;47:333-337
pubmed: 29958734
N Engl J Med. 2014 Oct 9;371(15):1381-91
pubmed: 25270275
Crit Care. 2018 Apr 19;22(1):102
pubmed: 29673409
Intensive Care Med. 2013 Mar;39(3):445-53
pubmed: 23184038
Lancet. 2015 Jul 11;386(9989):137-44
pubmed: 25956718
Intensive Care Med. 2005 Oct;31(10):1345-55
pubmed: 16132892
Int J Surg. 2014 Dec;12(12):1500-24
pubmed: 25046751
Crit Care Clin. 2017 Apr;33(2):345-364
pubmed: 28284299
Transfusion. 2018 Mar;58(3):804-815
pubmed: 29383722
N Engl J Med. 2017 Sep 28;377(13):1261-1272
pubmed: 28953438
N Engl J Med. 1999 Feb 11;340(6):409-17
pubmed: 9971864
Blood. 2005 Mar 15;105(6):2266-73
pubmed: 15572582
Intensive Care Med. 2020 Apr;46(4):673-696
pubmed: 31912207
Ann Intensive Care. 2020 Aug 8;10(1):111
pubmed: 32770427
Chest. 2007 May;131(5):1583-90
pubmed: 17494811
Intensive Care Med. 2003 Apr;29(4):530-8
pubmed: 12664219
JAMA. 2010 Oct 13;304(14):1559-67
pubmed: 20940381
Scand J Trauma Resusc Emerg Med. 2017 Jul 6;25(1):65
pubmed: 28683810
N Engl J Med. 2011 Dec 29;365(26):2453-62
pubmed: 22168590
JAMA. 2002 Sep 25;288(12):1499-507
pubmed: 12243637
Stat Med. 2011 May 20;30(11):1292-301
pubmed: 21337595
Cochrane Database Syst Rev. 2016 Oct 12;10:CD002042
pubmed: 27731885
N Engl J Med. 2013 Jan 3;368(1):11-21
pubmed: 23281973
N Engl J Med. 2015 Mar 12;372(11):997-1008
pubmed: 25760354

Auteurs

Thomas Kander (T)

Department of Clinical Sciences, Medical Faculty, Lund University, Lund, Sweden.
Department of Intensive and Perioperative Care, Skåne University Hospital, Lund, Sweden.

Caroline U Nilsson (C)

Department of Clinical Sciences, Medical Faculty, Lund University, Lund, Sweden.
Department of Intensive and Perioperative Care, Skåne University Hospital, Lund, Sweden.

Daniel Larsson (D)

Department of Clinical Sciences, Medical Faculty, Lund University, Lund, Sweden.

Peter Bentzer (P)

Department of Clinical Sciences, Medical Faculty, Lund University, Lund, Sweden.
Department of Anaesthesia and Intensive Care, Helsingborg lasarett, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH